In addition, heterozygous mutations in FH predispose patients to uterine leiomyomas (MCUL), hereditary leiomyomatosis, and renal cell cancer (HLRCC) [76]. The gene discussed is FH; the disease is hereditary leiomyomatosis and renal cell cancer.